Pro Medicus Limited (ASX:PME) Wins 7-Year $27 Million US Contract

Pro Medicus Limited (ASX:PME) has announced it has won a 7-year deal worth $27 million with Partners Healthcare in the US.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Australian software business Pro Medicus Limited (ASX: PME) announced Tuesday morning that it has won a 7-year deal worth $27 million with Partners Healthcare 

online pharmacy buy cialis-super-active online no prescription pharmacy

in the US.

Pro Medicus is a provider of radiology information systems, Picture Archiving and Communication Systems (PACS) and advanced visualization solutions.

Pro Medicus’ New US Contract

It has won a 7-year contract worth $27 million with Partners Healthcare, the largest health system in Massachusetts, it’s one of the largest health providers in North America.

The transaction licensing model contract will see Pro Medicus’ Visage 7 technology implemented at the Massachusetts General Hospital and Brigham and Women’s Hospital, there is scope to expand to other Partners’ hospitals in the future.

This deal has repositioned us in the market. Not only does it add to our rapidly growing North American footprint,” Pro Medicus CEO Dr Sam Hupert said.

“We now have two out of the top four US hospitals standardising on our platform, which we see a catalyst for growth in both North American and other global markets.”

The Pro Medicus share price was up almost 6% in early trade in response to this news.

Read Next: 3 Proven ASX Shares

The Rask Group Pty Ltd has issued its latest investing research report on 3 proven ASX dividend + growth sharesClick here to access the free report. No credit card or payment required. (sponsored)

online pharmacy purchase mobic no prescription with best prices today in the USA

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.